Related Experiment Video

Updated: Nov 23, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.6K

Immunomodulation and COVID-19: Is There a Winning Combination?

Srinivas Samavedam1

  • 1Department of Critical Care, Virinchi Hospital, Hyderabad, Telangana, India.

Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|January 1, 2021
PubMed

Insights

This study evaluated drug combinations for immunomodulation in COVID-19 patients. Researchers found no single combination definitively effective, highlighting the need for further research into effective COVID-19 treatments.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pharmacotherapy

Background:

  • Coronavirus disease-2019 (COVID-19) presents significant therapeutic challenges.
  • Pharmacotherapy for COVID-19 has yielded mixed results, with no universally effective drug identified.
  • Immunomodulatory strategies are being explored to manage COVID-19's complex pathophysiology.

Discussion:

  • Mahale et al. conducted a retrospective evaluation of drug combinations targeting immunomodulation in COVID-19.
  • The study aimed to identify a potentially effective therapeutic combination.
  • The findings contribute to the ongoing discussion on optimizing COVID-19 pharmacotherapy.

Key Insights:

  • Retrospective analysis of immunomodulatory drug combinations in COVID-19 patients.
  • Evaluation focused on identifying a "winning combination" for treatment.
  • Results underscore the complexity of COVID-19 pharmacotherapy and the search for effective interventions.

Outlook:

  • Further research is needed to establish definitive immunomodulatory treatment protocols for COVID-19.
  • Exploring novel drug combinations and therapeutic targets remains crucial.
  • Continued investigation into the role of immunomodulation in COVID-19 recovery is warranted.

Keywords:
COVID-19ImmunomodulationSARS-CoV-2Tocilizumab

More Related Videos

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.1K
Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection07:36

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Published on: February 28, 2021

3.2K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.3K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
82
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
877
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
146
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K